Novel combinations for treatment of recurrent cervical cancer

Drs. Bradley Monk and Wendel Naumann provide an overview of novel treatment options for recurrent cervical cancer, discuss combination therapy, and review recently completed clinical trials.

Description

Drs. Bradley Monk and Wendel Naumann provide an overview of novel treatment options for recurrent cervical cancer, discuss combination therapy, and review recently completed clinical trials.

Recorded on August 23, 2023
Duration approximately 35 minutes

Attended previous IGCS webinars? If you have attended IGCS webinars in the past, you may already have an IGCS account and creating a new account is not required. If unsure of your login information, you may reset your information by selecting "Forgot Password" at login or contact education@igcs.org.

Faculty Information

	Bradley Monk, MD Professor, Division of Gynecologic Oncology Arizona Oncology (US Oncology Network) University of Arizona College of Medicine Creighton University School of Medicine at St. Joseph’s Hospital Medical Director, US Oncology Research Network − Gynecologic Program USA
	Wendel Naumann, MD Moderator Director of Minimally Invasive Surgery in Gynecologic Oncology Carolinas Medical Center Associate Medical Director of Clinical Trials Associate Medical Director of Clinical Trials Levine Cancer Institute, Atrium Health USA

Supported in part by

Summary

Availability:

On-Demand

Cost:

FREE

Create Account

Recommended

Changing the standard of care in 2nd line recurrent cervical cancer

Hear from Dr. Brian Slomovitz as he provides a debrief on the ESMO Congress 2023 LBA innovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator’s choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer.

Free

Changing the standard of care in 2nd line recurrent cervical cancer - Webinar

Free

Second-Line Treatment Options for Patients with Recurrent Cervical Cancer. Review of Current Treatment and Future Directions

An overview of the InnovaTV 204 trial data along with InnovaTV 205 data, as well as ongoing trials including InnovaTV 301.

Free

Tumor Board: How new data in cervical cancer effects second-line treatment options

Recorded Live: August 31, 2022.

Free

Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications

This course offers an in-depth exploration of personalized treatment approaches for endometrial cancers, focusing on proficient mismatch repair (pMMR), deficient mismatch repair (dMMR) diseases and molecular classification in the recurrent setting.

Free

Redefining Platinum Sensitivity : Additional Treatment Considerations in a Changing Paradigm

Dr. Robert Coleman with moderation by Dr. Floor Backes and Dr. Wendel Naumman. Dr. Coleman explores the evolving treatment strategies for recurrent platinum-sensitive ovarian cancer, drawing on the latest clinical trial data and real-world outcomes.

Free

Precision in Endometrial Cancer: Personalized Treatment Strategies for pMMR and dMMR Endometrial Cancer

This interactive 90-minute symposium will explore the evolving treatment landscape in endometrial cancer, focusing on the distinctions between dMMR and pMMR disease.

Free

Uterine Cancers in the Molecular Era: Changing Trends and Implications

This 2-hour webinar will bring together international experts to explore evolving molecular insights, treatment trends, and clinical challenges in uterine cancer through lectures and a tumor board discussion.

Free

Surgical Film Library

Curated film collection reviewed by global surgical experts showcasing gynecologic oncology surgery procedures and techniques. Films provide practical learning through surgical demonstrations.

Free

IGCS 2024 Endometrial Cancer Master Session

Held at the IGCS 2024 Annual Global Meeting in Dublin, Ireland on October 16, 2024.

Free